Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 3Phase 1/2 2

Status

Recruiting 2Unknown 1

Sponsor Class

INDUSTRY 111OTHER 49NIH 6OTHER_GOV 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hematopoietic Recovery 1Hematologic Diseases 1Burkitt Lymphoma 1

Interventions

fludarabine 7Cyclophosphamide 7Nivolumab 6Metformin 4pembrolizumab 3fludarabine phosphate 3Radiotherapy 3Melphalan 3Ipilimumab 3Interleukin-2 3Injections 3S 1 (combination) 2Irinotecan 2tremelimumab 1selinexor 1parsaclisib 1olaparib 1nabiximols 1ivarmacitinib 1durvalumab 1defactinib 1decitabine and cedazuridine drug combination 1cedazuridine 1carfilzomib 1apatorsen 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Topotecan 1Rituximab 1Radiosurgery 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × OTHER_GOV × Injections × Clear all
NCT06558253 2024-12-18

The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT

Anhui Provincial Hospital

Phase 1 Recruiting
12 enrolled

Hematopoietic Recovery

NCT06056752 2023-10-24

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Anhui Provincial Hospital

Phase 1 Recruiting
10 enrolled
Lymphoid

Burkitt Lymphoma

NCT05755854 2023-09-22

Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors

Anhui Provincial Hospital

Phase 1 Unknown
10 enrolled

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡